Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine Mechanism in Functional Dyspepsia
NCT06213948Phase 1Recruiting
- Sponsor
- Universiti Sains Malaysia
- Start
- Aug 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of mirtazapine in functional dyspepsia (FD) (2 arms), sponsored by Universiti Sains Malaysia. Primary endpoints: Gastric volume (fasting and postprandial), Gastric emptying profile (4 hours) and 1 more. Started Aug 2021; status: recruiting.
02
Drugs
mirtazapine
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT06213948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06213948.